|
January 20, 2012 Dear Advocates, AVAC, amfAR and Health GAP invite you to join a webinar “The Impact of Treatment as Prevention: Models to Guide Ending the Epidemic”. The webinar will feature a presentation and discussion of the impact of expanded antiretroviral treatment on the AIDS epidemic in specific settings. The moderated discussion will help advocates focus on understanding how these impact models have been developed and what their implications are for beginning to end AIDS in 2012. This 60-minute webinar will take place on Thursday, January 26th at 9 AM EST/4 PM South Africa/5 PM East Africa (see www.timeanddate.com for the time in your area). The webinar will feature a presentation by Dr. John Blandford, chief of the Division of Global HIV/AIDS Health Economics, Systems, and Integration Branch at the US Centers for Disease Control and Prevention's Center for Global Health. Dr. Blandford will discuss work that he and his team have developed to project the impact of scaled-up antiretroviral treatment coverage on health, new infections and financial costs associated with the AIDS response. Work by Dr. Blandford and others has helped shape global discussions about the feasibility and potential of using treatment as prevention—including earlier treatment of HIV at CD4 counts greater than 350—as a key tool for ending the epidemic. The discussion will be moderated by Chris Collins, Vice President for Public Policy at amfAR, and Mitchell Warren, Executive Director of AVAC. Advocates interested in learning about how scaled-up investments in treatment and other prevention tools today could affect the epidemic over the long term are encouraged to join this webinar and to email questions in advance to avac@avac.org. Hope you will join us! Best, |
|||||||||||||||
| |||||||||||||||
